trending Market Intelligence /marketintelligence/en/news-insights/trending/nrbl7fzz9okihsvyuawqsg2 content esgSubNav
In This List

Spectrum Pharmaceuticals appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Spectrum Pharmaceuticals appoints board member

Henderson, Nev.-based Spectrum Pharmaceuticals Inc. added William Ashton to its board of directors.

Ashton was previously vice president for U.S. sales at Amgen Inc. His appointment expands the company's board to nine members.

Spectrum develops drug products for blood diseases and cancer.